✦ LIBER ✦

Patients with primary immunodeficiency receiving subcutaneous immune globulin Hizentra maintain health-related quality of life and treatment satisfaction in a multicentre extension study of efficacy, tolerability and safety

✍ Scribed by Christopher A. Jones; Mikhail Rojavin; Jeffrey S. Baggish

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Efficacy, Safety and Tolerability of a N

✍ Joseph A. Church; Heinz Leibl; Mark R. Stein; Isaac R. Melamed; Arye Rubinstein; 📂 Article 📅 2006 🏛 Springer 🌐 English ⚖ 443 KB

Health-Related Quality of Life and Treat

✍ Uwe Nicolay; Peter Kiessling; Melvin Berger; Sudhir Gupta; Leman Yel; Chaim M. R 📂 Article 📅 2006 🏛 Springer 🌐 English ⚖ 238 KB

Tolerability and Efficacy of Facilitated

✍ Wasserman, R.L.; Melamed, I.; Stein, M.; Puck, J.; Gupta, S.; Engl, W.; Leibl, H 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 41 KB

Safety and Pharmacokinetics of Facilitat

✍ Melamed, I.; Wasserman, R.L.; Stein, M.; Puck, J.; Gupta, S.; Engl, W.; Leibl, H 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 39 KB

Long-Term Tolerability and Safety Of Fac

✍ Melamed, Isaac Reuven; Wasserman, Richard L.; Stein, Mark; Rubinstein, Arye; Puc 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 41 KB